Caribou Biosciences is shutting down after failing to raise the money necessary to fund a late-stage clinical trial of its off-the-shelf CAR-T therapy for lymphoma.
Back to Lifestyle
Lifestyle
October 7, 2026 at 8:30 AM
STAT+: Caribou Biosciences, biotech co-founded by Jennifer Doudna, is shutting down
STAT News
Excerpt from STAT News.